Bausch Health Companies Inc BHC

NYS: BHC | ISIN: CA0717341071 16/10/2026

6,300 USD (-0,16%)

(-0,16%) 16/10/2026

Grafiek Bausch Health Companies Inc

Grafiek Bausch Health Companies Inc

1 dag1d -0,16%
1 week1w 6,24%
1 maand1m 11,11%
3 maanden3m 34,62%
6 maanden6m 6,60%
1 jaar1j -0,16%
5 jaar5j -77,56%

woensdag 28 oktober 2026, 21:00

Kwartaalcijfers (3de kwartaal)

Bausch Health Companies Inc in het nieuws

Toon enkel gratis nieuws

12 oktober 2026 · Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical Pathway · Persbericht

6 oktober 2026 · Bausch Health to Announce Third Quarter 2026 Results on October 28, 2026 · Persbericht

8 september 2026 · Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets · Persbericht

1 september 2026 · Bausch Health Announces Availability of Solta Medical's Fraxel FTX® in Australia · Persbericht

27 augustus 2026 · Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners · Persbericht

17 augustus 2026 · Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners · Persbericht

6 augustus 2026 · Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board · Persbericht

29 juli 2026 · Bausch Health Announces Second Quarter 2026 Results, Raises Guidance · Persbericht

7 juli 2026 · Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026 · Persbericht

1 juli 2026 · Michael Goettler Resigns from Bausch Health's Board of Directors · Persbericht

Profiel Bausch Health Companies Inc

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

Website: www.bauschhealth.com

Hoofdzetel: Laval Canada

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe